Target intelligence / Profile preview

MT-ND4 pseudogene 12 (MTND4P12)

Target: MTND4P12
Molecular classification: Other (Pseudogene)

Overview

MT-ND4 pseudogene 12 (MTND4P12) is classified as a pseudogene, meaning it is a non-coding DNA sequence with sequence similarity to the functional MT-ND4 gene, but does not produce an active protein or participate in mitochondrial complex I assembly or activity. Pseudogenes generally lack a biological function, do not serve as drug targets, and are not involved in known disease pathways. MT-ND4 pseudogene 12 is officially recognized by the HUGO Gene Nomenclature Committee as a pseudogene and is not a therapeutic target[4].

Other names: MTND4P12MT-ND4P12mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 12

Beyond the preview

Go deeper on MT-ND4 pseudogene 12 (MTND4P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND4 pseudogene 12 (MTND4P12).

Explore the full profile